George Sflomos
@sflomos
Followers
1K
Following
17K
Statuses
2K
Cancer Researcher passionate about Lobular Carcinoma, Preclinical Oncology, Discovery Science & Advocacy @LobularBCA Member ECR Council @EACRnews
Vaud, Switzerland
Joined March 2014
I'm thrilled to have been part of a successful collaboration between @CBrisken and @ChristineDesme2 labs, which has led to a key publication on #metastatic cancer. Great teamwork on this challenging project has led to crucial data that cannot be obtained otherwise #lobular
Proud to present our post-mortem tissue donation program #UPTIDER dedicated to advance research on metastatic breast cancer! @GeukensTatjana @MaxiMDpath @VanBaelenKaren @FendtLab @DiLa_lab @kevinpunie @HansWildiers #FRichard #GFloris #bcsm @OncoAlert
1
5
44
RT @BravoCorderoLab: Listening to the one and only, our @MetastasisRS president, Alana Welm! Amazing work on #breastcancer #metastasis @T…
0
3
0
RT @PatrikAouad: The human milk factory as never seen before. Improving the imaging of the human breast is essential in understanding its c…
0
7
0
RT @NatureRevCancer: 🥳 First up in #NRCtop10of2024: #10) Emerging strategies to investigate the biology of early cancer by Zhou, Tang and…
0
31
0
RT @MIgnatiadis: Our editorial on the NATALEE trial is out @Annals_Oncology @myESMO What are the key messages ? What are the limitatio…
0
7
0
RT @MIgnatiadis: 📣 The final analysis of the ALEXANDRA/IMpassion030 trial is now published in @JAMA_current A thread ⬇️ @EORTC_BCG @OncoAl…
0
12
0
RT @simocristea: ... and many more interesting details in the THREADS preprint, which is really well written & great to read. I expect thi…
0
2
0
RT @simocristea: Impressive advancement in Computational Pathology. A new multimodal foundation model by @AI4Pathology trained on 47,000 p…
0
100
0
RT @ElaineFuchsLab: Our first 2025 paper! We discuss in @NatRevMCB how epithelial stem cells mechanically sculpt tissues, and how these for…
0
37
0
RT @JAMouabbi: ✨ Exciting Results from #EMBER3! ✨ 💊 #Imlunestrant boosts PFS: 1. As monotherapy in #ESR1m patients 2. In combo with #abemac���
0
5
0
RT @JAMouabbi: In this era of ADC's, precision is the name of the game! 🚀 Don’t miss poster P01-03-19 at #SABCS24, where we unveil a compre…
0
9
0
RT @JAMouabbi: I have been saying this for years! After 1L progression in the metastatic setting we need routine MRI brain surveillance at…
0
8
0
RT @NatureRevCancer: #REVIEW 🚨 Hanahan, Michielin & Pittet discuss how, nearly all cell types in the tumour microenvironment can be progr…
0
30
0
RT @THEmeshwork2020: 🔔🛑‼️Fixing typos. Next event: Thursday, Feb. 6. Here is the complete program for next week's "Advances in Mechanobiolo…
0
10
0
RT @EricTopol: How microplastics can lead to reduced blood flow and blood clots in the brain @ScienceAdvances as s…
0
385
0
RT @EACRnews: In her #KeepResearchCurious article, EACR member Azadeh Kiumarsi explores how a curious mindset can bridge the gap between ca…
0
2
0
RT @CarlosC24501217: As a physician-scientist with a career spanning 3 countries (Portugal, USA, UK) over more than 30 years I could not ag…
0
6
0
RT @MammaryCell: 🧬 Drs. Ciara Metcalfe, Jackson Liang, and team members at @genentech studied the impact of ERα antagonist/degraders agains…
0
1
0